Samjo Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.35M Buy
316,670
+31,370
+11% +$330K 1.02% 28
2025
Q4
$3.36M Sell
285,300
-4,500
-2% -$48.5K 1.3% 25
2025
Q3
$2.24M Sell
289,800
-410,170
-59% -$2.87M 0.85% 33
2025
Q2
$5.12M Buy
699,970
+70,890
+11% +$572K 2.16% 18
2025
Q1
$5.97M Buy
+629,080
New +$7.85M 2.53% 11

Other funds holding NEO

Samjo Management's NEO Position: Q1 2026 in Review

Samjo Management increased its NeoGenomics (NEO) stake by 11% in Q1 2026, buying an estimated $330K and bringing the position to 316,670 shares worth $2.35M. The position accounts for 1.02% of the portfolio, ranked #28.

Samjo Management first reported a position in NEO in Q1 2025 and has held it in 5 quarters since. The position peaked at $5.97M in Q1 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Samjo Management held 316,670 shares of NeoGenomics worth $2.35M as of Q1 2026.
  • Samjo Management bought 31,370 NeoGenomics shares in Q1 2026, an estimated $330K.
  • NeoGenomics made up 1.02% of Samjo Management's portfolio in Q1 2026, its #28 holding.
  • Samjo Management first reported a position in NeoGenomics in Q1 2025 and has held it in 5 quarters since.
  • Samjo Management's NeoGenomics position peaked at $5.97M in Q1 2025.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Samjo Management's 13F filing for Q1 2026, filed 15 May 2026.